Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Keryx Biopharmaceuticals Company Profile (NASDAQ:KERX)

Consensus Ratings for Keryx Biopharmaceuticals (NASDAQ:KERX) (?)
Ratings Breakdown: 9 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.43 (85.72% upside)

Analysts' Ratings History for Keryx Biopharmaceuticals (NASDAQ:KERX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/4/2014Ladenburg ThalmannBoost Price TargetBuy$24.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014HC WainwrightReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/2/2014MizuhoBoost Price TargetBuy$25.00 -> $34.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014OppenheimerBoost Price TargetOutperform$20.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
3/20/2014MizuhoInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2014JMP SecuritiesReiterated RatingOutperform$25.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2014Stifel NicolausBoost Price TargetBuy$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2014Maxim GroupBoost Price TargetBuy$16.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
1/21/2014Roth CapitalBoost Price Target$30.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2013JPMorgan Chase & Co.Reiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Brean CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/4/2013JMP SecuritiesReiterated RatingOutperform$14.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
10/17/2013Ladenburg ThalmannBoost Price TargetBuy$15.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013Brean CapitalSet Price TargetPositive$20.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013Roth CapitalBoost Price Target$24.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2013Maxim GroupBoost Price TargetBuy$9.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
6/19/2013JPMorgan Chase & Co.Initiated CoverageOverweight$13.00ViewTweet This Rating  Share This Rating on StockTwits
6/19/2013JPMorgan Chase & Co.Reiterated RatingOverweight$13.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
5/17/2013OppenheimerReiterated RatingOutperform$11.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013Brean CapitalReiterated RatingBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2013OppenheimerBoost Price Target$11.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2013Ladenburg ThalmannBoost Price TargetBuy$5.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2013Stifel NicolausBoost Price TargetBuy$4.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2013MLV & Co.Boost Price TargetBuy$5.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Roth CapitalBoost Price TargetBuy$7.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Brean CapitalBoost Price TargetBuy$5.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Maxim GroupBoost Price TargetBuy$4.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
12/13/2012Maxim GroupInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
11/27/2012Dawson JamesInitiated CoverageOutperform$4.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2012Burrill Institutional ResearchInitiated CoverageOutperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2012Ladenburg ThalmannBoost Price TargetBuy$3.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2012OppenheimerReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
6/22/2012OppenheimerReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
6/22/2012Brean CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/11/2012OppenheimerReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
5/10/2012Ladenburg ThalmannUpgradeNeutral -> Buy$3.00ViewTweet This Rating  Share This Rating on StockTwits
5/10/2012Roth CapitalUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/23/2012 forward)